もうすぐにも使える 統計ソフト Stat Vie psykoba/ 私たちは、普段の臨床の中で、何らかの点で「患者に良くなって欲しい」と考えて、何 らかの介入をすることが多いでしょう。この「介入」には、薬を与えること、病気につい ての教育をすること、気持ちを落ち着かせてあげるよう ...

  • Published on
    02-May-2018

  • View
    219

  • Download
    3

Embed Size (px)

Transcript

  • 1

    Stat View

    StatView ANOVA

  • 2

    !"#$ %"#$

    &'()

  • 3

  • 4

    regression to the norm

    !"#

    $%&'()*%+,-.

    $%!/01)234,567

    8%!/073+,-.96'3:;)*+

    !

    "

    #

    $

    %

    &

    '

    (

    )

    "! #! $! %! &! '! *!

    +,-

    ./0123,45)6789:;< +,-+6?@A;@+

  • 24

    OK

    !"#$!!%%#&%'(#%"'!)

    %*#)))*"#)))

    )%!+#*!!#!!!$+#)))%)*!#)))$%'%"#)))!!#"*!!%#'%'#*)!#)%$!$#)))%$#)))!!#)))!$#"&!'#)))

    $(#+!!%)#&&*(#&%%%"

    ("#)))*"#)))

    )%%$+"#("$

    $)#)))*$$#)))(+!))))$%#*"&$)#!+"#$)+,#$&%$)#)))%%#'")

    -$(#*%"*#)))

    ('#+!!'#)&*%#&!)%"

    %*#)))$%#)))

    )")#(%)#("$("#)))$%+#)))%($)'#)))('#)$((*#%)&,#)*),#&*(('#)))%%#)))!!#)))('#&$**#)))

    ./01230143567897:9;?@AB6CDEF.GHIJ./KH./LMNMOP9Q>RS=CD7T9%)UVKW./OPXY23

    Z>[\VEF Z>[\VY]Z Z>[\V^_`a_Z

    bcdF,ef@6>g@6hijklaV Z>[

    50.210 118.495

    Mann-Whitney U

  • 25

    ANOVA

    ANOVA

  • 26

    PIL

  • 27

    0.001

  • 28

    ANOVA

    Mann-WhitneyU

  • 29

    1 4

    2 3

    1 4

    1 2

    2 3

    1 4

    2 1

    2 4

    1 2

    3 3

    StatView Mann-Whitney U

    StatView

  • 30

  • 31

    S

    !

    "#

    $

    $"#

    %

    %"#

    &

    &"#

    '

    '"#

    (

    )

    "# $ $"# % %"# & &"# ' '"#*+,

    -*./01234)56276589:;

    !

    $

    %

    &

    '

    #

    3@()*+,ABCDEFGHIJKLGCHIJKMNOPLGCNOP

    group2group1

    !

    "#

    $

    $"#

    %

    %"#

    &'()*+

    ! %! ,! -! .! $!! $%! $,! $-! $.!/0

    &'()*+123456%7&'()*+123456$7

    896:9;?>3@&'()*+ABCDEFGHIJKLGCHIJKMNOPLGCNOP

    group2group1

    group2

  • 43

    !"!#$ % "&$'!(")(! % "*#("#*( % "&*+((")&* % "#*!"&%# % "&*(!

    ,-(. /01 23456789:;?@A5BCD7>E?5F@G>H89@IJ?K5B59L8759>@I87>M>=5@M>=5@IJ?K5B59N877J96=59@O?>PJ96;7 Q

    RSTUVWXYZ[\]^_ZV[\]^`abc_ZVabc

    StatViewWindows

    Log rank test

    p=0.0653

    p

  • 44

    ID

    01 + +

    02 + +

    03 + -

  • 45

    04 - -

    05 - -

    06 + +

    07 - -

    08 - -

    09 - +

    10 + +

    11 + +

    12 + +

    13 - -

    14 + +

    15 - -

    16 + -

    17 + +

    18 + +

    19 - -

    20 - -

    StatView

  • 46

    StatView

    PO=/

    PC=/

    Kappa=(PO-PC)/(1-PC)

    ! " ##

    # $ !

    #% #% "%

    & ' ()

    &

    '

    ()

    *+,-./.01234.0125

    !

    "

    #$%##

    $!!"&

    ""$!"'

    $!!!#

    $(&(

    $&!)

    &$*&+

    $!!&!

    $!!((

    ,-./

    012

    3456.

    345678.

    956.

    95678.

    :;/

    ?@4

    3456.ABCDEFGHI

    345678.ABCDEFGHI

    JKFLEMNOPQ78.

    :;

  • 47

    0.70

    0.7 0.8

    SST

    !

    "

    #$%##

    $!!"&

    ""$!"'

    $!!!#

    $(&(

    $&!)

    &$*&+

    $!!&!

    $!!((

    ,-./

    012

    3456.

    345678.

    956.

    95678.

    :;/

    ?@4

    3456.ABCDEFGHI

    345678.ABCDEFGHI

    JKFLEMNOPQ78.

    :;

  • 48

    ICC

    (Intra Class Correlate)

    ICC

    ID

    01 4 4

    02 1 1

    03 2 3

    04 1 1

    05 4 4

    06 4 3

    07 1 1

    08 2 2

    09 3 2

    10 3 3

  • 49

    11 4 4

    12 1 1

    13 1 1

    14 4 4

    15 2 2

    ICC StatView

    repeated measure ANOVA ANOVA

    ANOVA

  • 50

    C N ANOVA ANOVA

  • 51

    repeated measure ANOVAOK

    ICC

    MSB==3.133 MSW=(+/(+

    = ( 0.33 + 1.467 ) / (1 + 14 ) = 0.1198 ICC

    !" "#$%&' #$!##

    ! $(## $(## $#!% $)%!&

    !" !$"&' $!()

    *+, -./ -0-. 12 32

    45

    6789:;?

    6789:;?;@;45

    ABCDEF2;G;HIJK;$L&%M;NIJK;$L#%

    OPOQR;K;?

    !) S$"&' !$#(S $##&

    !) S$"(( !$S"S $#S!

    TU -02 VWXY VWZY

    [

    \

    ]^_`a;K;?

    bcK;6789:;?

  • 52

    ICC=(MSB-MSW) / (MSB+MSW) =(3.133-0.1198) / (3.133+0.1198) =0.93

    StatView

    Spearmann

    5 1 3

    10 3 7

    ICC

  • 53

    OK

    0.954

    !"#"$$

    #%"&

    '#"()

    #$$$&

    #%")

    '#""*

    #$$$&

    &

    &

    +,-./

    01

    21

    31

    4567801

    4569:;,21

    4569:;,31

    456?@AB

    456?@AC

    D3EFGHFI,56JK>L>?@ABM>?@AC

  • 54

    Between Subject Design Within Subject Design

    StatView

    Between Subject Design

    Within Subject Design

    Between Subject Design

    Within Subject Design

    Between Subject DesignWithin Subject Design

    Within Subject Design

  • 55

    SSRI

    SSRI

    group1 group2

    01 group1 12 8

    02 group1 5 2

    03 group1 28 22

    04 group1 16 12

    05 group1 55 35

    06 group1 8 4

    07 group2 28 35

    08 group2 10 15

    09 group2 18 25

    10 group2 6 8

    11 group2 45 50

    12 group2 3 3

    Within Subject Design

  • 56

    ANOVA

    group

    Two-way Repeated Measure ANOVAgroup group

  • 57

    repeated measure

    OK

  • 58

    ! "#$#%& "#$#%& $!'! $%#()

    !* &''($%&* &''$(%&

    ! )$#%& )$#%& $%(( $(*+%

    ! !+%$*(' !+%$*(' !($+#& $**#'

    !* !'"$*+# !'$"*+

    ,-. /01 /2/0 34 54

    67895

    :;?@

    ABCDEFGHIJK

    ABCDEFGHIJKFLF67895

    ABCDEFGHIJKFLF:;

  • 59

    p 0.40 group1

    group1

    group

    group1group2

    two-way repeated measure ANOVA

    p=0.032 group p=0.4089group

    ! "#$#%& "#$#%& $!'! $%#()

    !* &''($%&* &''$(%&

    ! !+%$*(' !+%$*(' !($+#& $**#'

    ! )$#%& )$#%& $%(( $(*+%

    !* !'"$*+# !'$"*+

    ,-. /01 /2/0 34 54

    67895

    :;?@

    ABCDEFGH

    ABCDEFGHFIF67895

    ABCDEFGHFIF:;J

    KLKMNFOFGH

  • 60

    Within Subject Design Two-way Repeated

    Measure ANOVA Within Subject DesignBetween Subject Design

    Between Subject Design SSRI SSRI

    !"

    !#

    !$

    !%

    !&

    !'

    !(

    )*

    )!

    ))

    )"

    +,-./01

    234 534+,-

    6789:)

    6789:!

    ;?@ABCDEFEGHIJFEKLMNOEGHEPE6789:

Recommended

View more >